Alexis Hubaud

Alexis Hubaud has worked in a variety of roles in the biopharmaceutical industry since 2008. In 2008, they were a Teaching Assistant at Lycée Henri IV. In 2009, they were a Visiting Student at Yale School of Medicine and an Intern at the University of Washington. In 2010, they were a Master Student at IGBMC. From 2011 to 2014, they were a Graduate Student at Université de Strasbourg and IGBMC. From 2016 to 2017, they were a Postdoctoral Fellow at Harvard Medical School / Brigham and Women's Hospital. From 2017 to 2020, they were a Postdoctoral Scholar at Novartis Institutes for BioMedical Research (NIBR). Since 2020, they have been a Senior Scientist at Inzen Therapeutics, and they are currently a Senior Scientist at Be Biopharma.

Alexis Hubaud began their educational journey in 2005 at Lycée Henri IV, where they completed Classes preparatoires in Biology, General. From 2007 to 2010, they attended Ecole normale supérieure and earned a Bachelor's degree in Cell/Cellular and Molecular Biology. In 2010 and 2011, they studied at Sorbonne University and earned a Master of Science (M.S.) in Developmental and Stem Cell Biology. Finally, from 2011 to 2016, they attended University of Strasbourg and earned a Doctor of Philosophy (PhD) in Developmental and Stem Cell Biology. Additionally, Hubaud has obtained two certifications from Coursera: Northwestern University's High Performance Collaboration: Leadership, Teamwork, and Negotiation in December 2019 and UPenn's The Economics of Health Care Delivery in September 2019.